Funt, Samuel A.
Rosenberg, Jonathan E.
Article History
First Online: 22 November 2016
Competing interests
: S.A.F. declares stock ownership in Kite Pharma. J.E.R. has been a consultant for Agensys, Eli Lilly, Roche and Sanofi, and declares a patent interest in ERCC2 testing for cisplatin sensitivity.